MALIGNANCIES IN MAN AFTER ORGAN-TRANSPLANTATION

MALIGNANCIES IN MAN AFTER ORGAN-TRANSPLANTATION

Detalhes bibliográficos
Autor principal:	Kinlen, L
Formato:	Conference item
Publicado em:	1991

Registos relacionados

Malignancy and immunosuppression.
Por: Kinlen, L
Publicado em: (1972)

Malignancy in autoimmune diseases.
Por: Kinlen, L
Publicado em: (1992)

CYCLOPHOSPHAMIDE, AZATHIOPRINE, AND MALIGNANCY
Por: Kinlen, L
Publicado em: (1977)

Everolimus and Malignancy after Solid Organ Transplantation: A Clinical Update
Por: Hallvard Holdaas, et al.
Publicado em: (2016-01-01)

Malignancies after renal transplantation
Por: Bastiaannet, E, et al.
Publicado em: (2010)

Malignancies After Lung Transplantation
Por: Caroline Stenman, et al.
Publicado em: (2024-09-01)

Malignancies After Heart Transplantation
Por: Caroline Stenman, et al.
Publicado em: (2024-09-01)

Urological malignancy after renal transplantation.
Por: Besarani, D, et al.
Publicado em: (2007)

The potential advantages of transplanting organs from pig to man: A transplant Surgeon′s view
Por: Carl G Groth
Publicado em: (2007-01-01)

Hepatocyte Transplantation in Man
Por: Michio Mito, et al.
Publicado em: (1993-01-01)

A study of cancer of the breast and other sites in women after total colectomy and ileostomy for non-malignant disorders.
Por: Rang, E, et al.
Publicado em: (1983)

De novo malignancies after kidney transplantation
Por: Giuseppina Rosso, et al.
Publicado em: (2024-11-01)

Lymphomas in renal transplant recipients: a search for clustering.
Por: Kinlen, L, et al.
Publicado em: (1979)

Malignant skin neoplasms in patients after kidney transplantation
Por: D. V. Perlin, et al.
Publicado em: (2022-10-01)

Late Malignant Oral Lesions after Kidney Transplantation
Por: Paulo Sérgio da Silva Santos, et al.
Publicado em: (2023-03-01)

Man and ecosystems : man and communities of organisms
Por: Open University. Ecology Course Team
Publicado em: (1974)

Donors With Previous Malignancy: When Is It Safe to Proceed With Organ Transplantation?
Por: Vitor Turra, et al.
Publicado em: (2025-01-01)

THE INCIDENCE OF TUMORS IN HUMAN TRANSPLANT RECIPIENTS
Por: Kinlen, L, et al.
Publicado em: (1983)

Immunotherapy and Antivascular Targeted Therapy in Patients’ Treatment with Concurrent Malignant Tumors after Organ Transplantation: Opportunity or Challenge
Por: Bairu Shen, et al.
Publicado em: (2022-01-01)

Extrahepatic malignant neoplasms after liver transplantation: the experience of a single transplant center
Por: O. A. Gerasimova, et al.
Publicado em: (2020-02-01)

Immunity after organ transplantation
Por: Swiss Medical Weekly
Publicado em: (2006-02-01)

Allograft Transplantation and Reconstruction of Bones after Malignant Tumor Resections.
Por: Rezeart Dalipi, et al.
Publicado em: (2022-01-01)

Malignancies after kidney transplantation: 3 clinical case reports
Por: Dalinkevičienė Eglė, et al.
Publicado em: (2013-06-01)

Non-Hodgkin's lymphoma after immunosuppressive therapy.
Por: Kinlen, L
Publicado em: (2000)

Idiopathic Organ Transplant Chorioretinopathy after Liver Transplantation
Por: Maria Fernanda Abalem, et al.
Publicado em: (2015-01-01)

P1375: SECOND PRIMARY MALIGNANCY AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
Por: T.-D. Tan, et al.
Publicado em: (2022-06-01)

Characteristics, outcomes, and predictors of de novo malignancy after heart transplantation
Por: Jong-Chan Youn, et al.
Publicado em: (2022-08-01)

Post-transplant malignancies in solid organ recipients: development mechanisms and risk factors
Por: A. V. Nikulin, et al.
Publicado em: (2021-09-01)

Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment.
Por: Kinlen, L
Publicado em: (1985)

An economic efficacy of organ transplantation after the example of kidney transplantation
Por: M. Sh. Khubutia
Publicado em: (2018-08-01)

Comparable Outcomes for Hematologic Malignancies after HLA-Haploidentical Transplantation with Posttransplantation Cyclophosphamide and HLA-Matched Transplantation
Por: Shannon R. McCurdy, et al.
Publicado em: (2015-01-01)

Malignancy in Renal Transplant Recipients
Por: Ergün Parmaksız, et al.
Publicado em: (2019-03-01)

Conventional human as organization man
Publicado em: (1392-07-01)

Use of immune checkpoint inhibitors in solid organ transplant recipients with advanced cutaneous malignancies
Por: Stephanie Ji, et al.
Publicado em: (2023-10-01)

Multicenter analysis of immunosuppressive medications on the risk of malignancy following adult solid organ transplantation
Por: Reid Shaw, et al.
Publicado em: (2023-06-01)

Post-transplant outcome of ovarian tissue cryopreserved after chemotherapy in hematologic malignancies
Por: Catherine Poirot, et al.
Publicado em: (2019-08-01)

Long-term Survival in a Child with Malignant Insulinoma After Liver Transplantation
Por: Elzbieta Moszczynska, et al.
Publicado em: (2024-03-01)

Review of Outcomes after Diagnosis of Malignancy in Kidney Transplant Patients: UNOS Database
Por: Het Patel, et al.
Publicado em: (2021-06-01)

Incidence of malignancies after lung transplantation and their effect on the outcome. 26 years' experience
Por: Konstantina Spetsotaki, et al.
Publicado em: (2023-10-01)

Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy
Por: Rivinius R, et al.
Publicado em: (2014-12-01)